Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A novel chronic lymphocytic leukemia subset expressing mutated IGHV3-7-encoded rheumatoid factor B-cell receptors that are functionally proficient.

× No keyword cloud information.

19 in total

1. Identification of a novel stereotypic IGHV4-59/IGHJ5-encoded B-cell receptor subset expressed by various B-cell lymphomas with high affinity rheumatoid factor activity.

Authors: Richard J Bende; Jerry Janssen; Thera A M Wormhoudt; Koen Wagner; Jeroen E J Guikema; Carel J M van Noesel
Journal: Haematologica Date: 2016-02-08 Impact factor: 9.941

Review 2. B cell receptor signaling in chronic lymphocytic leukemia.

Authors: Jan A Burger; Nicholas Chiorazzi
Journal: Trends Immunol Date: 2013-08-05 Impact factor: 16.687

3. In vitro induction of antibody secretion of primary B-cell chronic lymphocytic leukaemia cells.

Authors: R Hoogeboom; R J A Reinten; J-J Schot; J E J Guikema; R J Bende; C J M van Noesel
Journal: Leukemia Date: 2014-09-10 Impact factor: 11.528

Review 4. Bruton's tyrosine kinase (BTK) inhibitors in clinical trials.

Authors: Jan A Burger
Journal: Curr Hematol Malig Rep Date: 2014-03 Impact factor: 3.952

5. TLR-9 and IL-15 Synergy Promotes the In Vitro Clonal Expansion of Chronic Lymphocytic Leukemia B Cells.

Authors: Patricia K A Mongini; Rashmi Gupta; Erin Boyle; Jennifer Nieto; Hyunjoo Lee; Joanna Stein; Jela Bandovic; Tatjana Stankovic; Jacqueline Barrientos; Jonathan E Kolitz; Steven L Allen; Kanti Rai; Charles C Chu; Nicholas Chiorazzi
Journal: J Immunol Date: 2015-07-01 Impact factor: 5.422

Review 6. Microenvironment interactions and B-cell receptor signaling in Chronic Lymphocytic Leukemia: Implications for disease pathogenesis and treatment.

Authors: Elisa Ten Hacken; Jan A Burger
Journal: Biochim Biophys Acta Date: 2015-07-17

A novel chronic lymphocytic leukemia subset expressing mutated IGHV3-7-encoded rheumatoid factor B-cell receptors that are functionally proficient.

1. Identification of a novel stereotypic IGHV4-59/IGHJ5-encoded B-cell receptor subset expressed by various B-cell lymphomas with high affinity rheumatoid factor activity.

Review 2. B cell receptor signaling in chronic lymphocytic leukemia.

3. In vitro induction of antibody secretion of primary B-cell chronic lymphocytic leukaemia cells.

Review 4. Bruton's tyrosine kinase (BTK) inhibitors in clinical trials.

5. TLR-9 and IL-15 Synergy Promotes the In Vitro Clonal Expansion of Chronic Lymphocytic Leukemia B Cells.

Review 6. Microenvironment interactions and B-cell receptor signaling in Chronic Lymphocytic Leukemia: Implications for disease pathogenesis and treatment.

Review 7. Structural Basis of a Conventional Recognition Mode of IGHV1-69 Rheumatoid Factors.

8. Basal Ca(2+) signaling is particularly increased in mutated chronic lymphocytic leukemia.

Review 9. Chronic lymphocytic leukaemia: could immunological tolerance mechanisms be the origin of lymphoid neoplasms?

Review 10. Targeting Bruton's tyrosine kinase in B cell malignancies.